Want to see HK:9686 full AI Analyst Report?
9686 Stock Chart & Stats
HK$0.90
HK$0.07(8.97%)
At close: 4:00 PM EST
HK$0.90
HK$0.07(8.97%)
Day’s Range― - ―
52-Week RangeHK$0.45 - HK$1.03
Previous CloseN/A
Volume78.50K
Average Volume (3M)44.03K
Market Cap
HK$833.46M
Enterprise ValueHK$619.04
Total Cash (Recent Filing)HK$662.49M
Total Debt (Recent Filing)HK$491.53M
Price to Earnings (P/E)―
Beta0.21
Next Earnings
Mar 25, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding841,877,800
10 Day Avg. Volume98,000
30 Day Avg. Volume44,033
Financial Highlights & Ratios
PEG Ratio0.33
Price to Book (P/B)2.17
Price to Sales (P/S)1.47
P/FCF Ratio45.59
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue ReboundThe sharp TTM revenue rebound indicates improving demand and renewed top-line momentum after two years of contraction. If sustained, stronger revenue can improve operating leverage, support reinvestment, and provide a larger base from which management can complete the broader turnaround.
Positive Cash GenerationThe shift to positive operating and free cash flow is a meaningful improvement in financial quality, because it shows the business is generating cash despite reported losses. Continued cash generation could fund operations internally and reduce reliance on external financing over coming quarters.
Narrowing Losses And Positive EquityNarrower losses and a positive equity base suggest the company has made measurable progress from earlier periods of financial weakness. Although the turnaround is incomplete, improving profitability and restored balance-sheet equity provide a stronger platform for stabilizing operations and pursuing growth.
Bears Say
Persistent UnprofitabilityThe company has not yet converted improved demand into sustainable operating profitability. Negative EBIT and EBITDA mean gross profit remains insufficient to cover operating costs, leaving earnings vulnerable if growth slows and limiting internally generated funds available for strategic investment.
Elevated And Rising LeverageHigher debt relative to equity increases financial risk while the company remains loss-making. Elevated leverage can constrain capital allocation, raise the importance of consistent cash generation, and reduce flexibility to absorb execution setbacks or invest aggressively in expansion.
Weak Debt Cash-flow CoveragePositive cash flow is encouraging, but its limited scale relative to outstanding debt means the balance sheet remains dependent on continued improvement. Low coverage reduces the cushion available for debt service and leaves less room for operational volatility before financing pressure could intensify.
NEUSOFT XIKANG HOLDINGS INC. News
9686 FAQ
What was NEUSOFT XIKANG HOLDINGS INC.’s price range in the past 12 months?
NEUSOFT XIKANG HOLDINGS INC. lowest stock price was HK$0.45 and its highest was HK$1.03 in the past 12 months.
What is NEUSOFT XIKANG HOLDINGS INC.’s market cap?
NEUSOFT XIKANG HOLDINGS INC.’s market cap is HK$833.46M.
When is NEUSOFT XIKANG HOLDINGS INC.’s upcoming earnings report date?
NEUSOFT XIKANG HOLDINGS INC.’s upcoming earnings report date is Mar 25, 2027 which is in 175 days.
How were NEUSOFT XIKANG HOLDINGS INC.’s earnings last quarter?
NEUSOFT XIKANG HOLDINGS INC. released its earnings results on Aug 26, 2026. The company reported -HK$0.037 earnings per share for the quarter.
Is NEUSOFT XIKANG HOLDINGS INC. overvalued?
According to Wall Street analysts NEUSOFT XIKANG HOLDINGS INC.’s price is currently Overvalued.
Does NEUSOFT XIKANG HOLDINGS INC. pay dividends?
NEUSOFT XIKANG HOLDINGS INC. does not currently pay dividends.
What is NEUSOFT XIKANG HOLDINGS INC.’s EPS estimate?
NEUSOFT XIKANG HOLDINGS INC.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NEUSOFT XIKANG HOLDINGS INC. have?
NEUSOFT XIKANG HOLDINGS INC. has 841,877,800 shares outstanding.
What happened to NEUSOFT XIKANG HOLDINGS INC.’s price movement after its last earnings report?
NEUSOFT XIKANG HOLDINGS INC. reported an EPS of -HK$0.037 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of NEUSOFT XIKANG HOLDINGS INC.?
Currently, no hedge funds are holding shares in HK:9686
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
NEUSOFT XIKANG HOLDINGS INC. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-2.76%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
NEUSOFT XIKANG HOLDINGS INC.
Xikang Cloud Hospital Holdings Inc. specializes in constructing customized digital healthcare platforms designed for urban settings. Its business operations are structured into four main categories: Cloud Hospital Platform Services, Internet Medical Services, Health Management Services, and Smart Healthcare Products. The Cloud Hospital Platform Services unit provides advanced technological solutions to local governmental bodies, medical institutions, and insurance providers. Through its Internet Medical Services, the company offers a range of options including virtual hospital consultations, remote medical support, intelligent family physician initiatives, and online home care assistance. The Health Management Services division delivers comprehensive wellness oversight and specific chronic condition management programs. Lastly, the Smart Healthcare Products segment markets innovative health-related devices to a broad customer base, encompassing municipal authorities, primary care facilities, businesses, and individual consumers. The company was founded on May 12, 2011, and its headquarters are situated in Shanghai, China.
Technical Analysis
EC Healthcare
―
Beijing Airdoc Technology Co. Ltd. Class H
―
Yonghe Medical Group Co., Ltd.
―
Town Health International Medical Group Ltd.
―
UMP Healthcare Holdings Limited
―